paclitaxel has been researched along with Foot Dermatoses in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chao, TY; Hong, RL; Hsieh, RK; Hwang, WS; Kao, WY; Lin, CH; Wang, CH | 1 |
Fujino, M; Maruhashi, K; Mitsudou, Y; Nakamura, T; Shimomatsuya, T; Shiraishi, S; Yonezawa, K | 1 |
Baker, WJ; Burris, HA; Keeling, JH; Von Hoff, D; Vukelja, SJ | 1 |
de Argila, D; Dominguez, JD; Iglesias, L | 1 |
Belinson, J; Kennedy, A; Kulp, B; Markman, M; Peterson, G; Webster, K | 1 |
Inbar, MJ; Merimsky, O | 1 |
2 trial(s) available for paclitaxel and Foot Dermatoses
Article | Year |
---|---|
A phase-I study evaluating the combination of pegylated liposomal doxorubicin and paclitaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracycline.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Drug Administration Schedule; Female; Fever; Foot Dermatoses; Hand Dermatoses; Humans; Liposomes; Maximum Tolerated Dose; Middle Aged; Neoplasm Metastasis; Neutropenia; Paclitaxel; Paresthesia; Polyethylene Glycols; Salvage Therapy; Treatment Outcome | 2008 |
Phase 2 trial of liposomal doxorubicin (40 mg/m(2)) in platinum/paclitaxel-refractory ovarian and fallopian tube cancers and primary carcinoma of the peritoneum.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Doxorubicin; Drug Carriers; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Erythema; Fallopian Tube Neoplasms; Female; Foot Dermatoses; Hand Dermatoses; Humans; Liposomes; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Stomatitis; Stroke Volume | 2000 |
4 other study(ies) available for paclitaxel and Foot Dermatoses
Article | Year |
---|---|
[A case of severe hand-foot syndrome caused by capecitabine].
Topics: Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Deoxycytidine; Drug Administration Schedule; Female; Fluorouracil; Foot Dermatoses; Hand Dermatoses; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Middle Aged; Paclitaxel; Paresthesia; Postoperative Period; Syndrome | 2007 |
Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with taxotere.
Topics: Antineoplastic Agents, Phytogenic; Docetaxel; Erythema; Female; Foot Dermatoses; Hand Dermatoses; Humans; Male; Middle Aged; Paclitaxel; Paresthesia; Pyridoxine; Taxoids | 1993 |
Taxol-induced acral erythema.
Topics: Adult; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Erythema; Female; Foot Dermatoses; Hand Dermatoses; Humans; Paclitaxel | 1996 |
Herceptin-taxol related hand and foot syndrome.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Drug Eruptions; Female; Foot Dermatoses; Hand Dermatoses; Humans; Paclitaxel; Syndrome; Trastuzumab | 2000 |